hVIVO plc
hVIVO plc (OPORF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · OPORF · as of Jun 9, 2026
Key Statistics
Explore hVIVO plc Data
oporf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
oporf competitorsOPORF
BHCCF
EVGRF
FGHQF
GNFTF
HNSBFStock Performance
Full HistoryAbout hVIVO plc
hVIVO plc functions as a contract research organization and pharmaceutical service provider, primarily dedicated to evaluating vaccines and antiviral medications. This is achieved through specialized …
what is hvivo plc · oporf stock overview · hvivo plc company profile · who is hvivo plc ceo · oporf OTC · hvivo plc headquarters · hvivo plc business segments
About Stock Overview & Key Data
hVIVO plc (OPORF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jun 5, 2020. As of the latest trading session, OPORF stock price is $0.35, with a market capitalization of $240.9M. The stock has returned +45.83% over the past 12 months and +45.83% year-to-date.
In fiscal year 2025, hVIVO plc reported revenue of $46.8M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, hVIVO plc (OPORF) stock price is $0.35. The stock is traded on OTC under the ticker symbol OPORF. The 52-week range is $0.09 – $0.35.